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Abstract: Most women experience some premenstrual symptoms during their reproductive years. 
Yet, this is an under-researched health issue, particularly in the context of work. This study aimed 
to: (i) understand the prevalence and severity of premenstrual symptoms experienced by working 
females, and their association with key work outcomes; (ii) explore factors that may be influencing 
these symptoms and their severity; and (iii) examine how organizations might help staff with pre-
menstrual symptoms that may be impacting their working lives. An online, anonymous survey col-
lected quantitative and qualitative data from 125 working women in the UK. Over 90% of the sample 
reported some premenstrual symptoms; 40% experienced premenstrual symptoms moderately or 
severely. Higher symptom severity was significantly (p < 0.05) associated with poor presenteeism, 
intention to reduce working hours, and higher work absence (time off work, being late, leaving 
early). Moderate/severe symptoms were significantly associated with several individual-related 
variables: lower perceived general health, higher alcohol consumption, poorer sleep quality, anxi-
ety, depression, hormonal contraception, and using fewer coping approaches towards premenstrual 
symptoms (avoiding harm, adjusting energy levels); and work-related variables: poorer work–life 
balance, lower levels of psychological resilience, higher perceived work demands, less control over 
work. Disclosure of premenstrual symptoms and sickness absence because of premenstrual symp-
toms was very low, typically because of perceptions of appropriateness as a reason for work ab-
sence, gender of line managers (male), and it being a personal or embarrassing topic. Staff with 
moderate to severe premenstrual symptoms were statistically more likely to disclose reason for ab-
sence than those with milder symptoms. Recommendations and suggestions for employers and line 
managers include the need to train staff to improve knowledge about women’s experience of pre-
menstrual symptoms, to be able to communicate effectively with women and to provide tailored 
support and resources for those who need it. Implications for future research, policy and practice 
are discussed. 
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1. Introduction 
Menstruation is a naturally occurring phenomenon for women. Typically experi-
enced between the ages of 13–51 years in Western cultures [1], menstruation is commonly 
preceded by some bodily sensations or symptoms, for up to 90% of women [2]. These are 
often described as either psychological, such as anxiety, depression, mood swings, or 
physical, including bloating, headaches, breast tenderness, which typically last between 
7–14 days before stopping when menses begins [3]. The duration, frequency, and severity 
of symptoms varies between women [4]. Some women may experience little of no disrup-
tion whilst others experience premenstrual symptoms that negatively impair normal 
functioning whilst symptoms are present. They can vary from month to month for each 
individual but typically a pattern is experienced [3]. 
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Two conditions typically associated with severe premenstrual symptoms are Pre-
menstrual Syndrome (PMS) and a more severe form of PMS called Premenstrual Dys-
phoric Disorder (PMDD). Both reflect the cyclical presentation of multiple symptoms that 
are severe enough to disrupt everyday life. PMS typically involves moderate to severe 
presentation of at least two symptoms (one physical and one psychological) and PMDD 
involving five or more symptoms that impact on normal functioning during this time in 
the menstrual cycle only (also with specific symptom type presentation; see the World 
Health Organization’s International Classification of Disorders (ICD) [5] and American 
Psychological Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM-
V) [6] for more specific diagnostic information). Around 40–50% of females may experi-
ence premenstrual symptoms regularly and severely enough to receive a diagnosis of 
PMS [2,7] and around 5% may have PMDD [4]. Estimates have changed overtime and 
vary depending on the measurements and criteria used [8]. However, use of terms such 
as “PMS” and “PMDD” has been criticized for pathologizing a normal part of women’s 
experience, and also because someone may experience one symptom severely enough to 
impact on daily life, yet not receive a diagnosis nor support (e.g. [9,10]). 
Nevertheless, the impact of premenstrual symptoms, however, can be considerable 
for women, their families, and society [11]. For example, women may experience around 
3000 days of difficult or problematic premenstrual symptoms over the course of their re-
productive years [12]. 
1.1. Premenstrual Symptoms and Work 
A growing body of evidence is highlighting the importance of addressing premen-
strual health in the work context. To date, research has primarily focused on the relation-
ship between premenstrual symptom severity and the rates of absenteeism, job perfor-
mance and productivity. Several studies have shown reductions in work productivity, 
performance, and higher absence from work in staff who reported problematic premen-
strual symptoms (e.g. [13–20]), with very few exceptions (e.g. [21]). Borenstein and col-
leagues [13] found a 13.7% absenteeism rate (days taken as absence) for women with pre-
menstrual symptoms and a 15% reduction in work productivity (N = 364). Chawla [14] 
found taking half days off work were more common than taking full days of absence in 
women with premenstrual symptoms. 
Borenstein and colleagues [13] estimated the indirect costs associated with such work 
impairments in the USA to be an increase of $4333 per individual per year compared to 
those without PMS. However, rates of absence were believed to be under-estimated due 
to the taboo nature of the health issue, i.e., staff may have felt too embarrassed to report 
premenstrual symptom difficulty and may have given other reasons for their absence 
leading to a lower number of reported cases. 
According Gatrell and colleagues [22], women’s bodies being ‘unstable and uncontrol-
lable’ are often viewed unfavorably compared to men’s in organizational contexts-being af-
fected by menstruation, pregnancy, motherhood or non-motherhood, and the menopause. 
Women may be aware of negative attitudes at work and therefore decide not to draw atten-
tion to female-specific experiences related to their rebodies. Lack of disclosure, as well as 
fears around disclosing premenstrual related difficulties at work, has been found in a one 
qualitative study of women with a diagnosis of PMDD [17]. For example, some women with 
PMDD did not disclose this to their line managers for fear of a negative response or being 
stigmatized if they confided in them or work colleagues. In instances when disclosure did 
occur, a mixture of positive and negative responses was reported. The women expressed a 
need for more awareness, understanding and support within the workplace. Further explo-
ration of negative attitudes and disclosure is needed as some staff may be experiencing dif-
ficulties but not getting any help or support from their workplace. 
The potential impact of premenstrual symptoms on work outcomes is an important 
research question. Although under-researched, there appears to be some consistency in sup-
porting the view that impairment of performance and/or productivity and absenteeism rates 
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may be reported by women with moderate or severe premenstrual symptoms. What we do 
not yet fully understand is the possible influence of premenstrual experiences on other work 
outcomes, such as presenteeism (i.e. being at work when not 100%), and intention to leave 
the organization or working altogether [17,23]. In the study by Hardy and Hardie [17], levels 
of presenteeism (i.e. being at work when not 100% because of their premenstrual symptoms) 
were evident for staff with severe premenstrual symptoms/PMDD, as were impaired job 
performance and needing to take time off work. Over time, the women in the study reported 
that the cyclical pattern of premenstrual symptoms and their impact on their working life 
affected their work life balance, as staff attempted to compensate for their impaired time at 
work of absence by working longer hours. Ultimately, this led to some of these women leav-
ing their jobs or being asked to leave and negatively impacted on the woman’s career, which 
some said they had to give up on altogether. Research is therefore needed to examine a 
wider range of work outcomes, as well as work-related factors that might be associated with 
premenstrual symptoms and their severity. 
1.2. Aims and Research Questions 
This paper aims to: (i) understand the prevalence and severity of premenstrual symp-
toms in working females and their association with key work outcomes; (ii) explore factors 
that may be influencing these symptoms and their severity; and (iii) examine how organ-
izations might help staff whose working lives are impacted by premenstrual symptoms. 
Using cross-sectional data collected from a UK trade union’s women’s health survey, this 
paper poses the following research questions: 
1. What is the prevalence and severity of premenstrual symptoms in a sample of work-
ing women in the UK? 
2. To what extent does premenstrual symptom severity relate to work absenteeism, job 
performance, presenteeism, and turnover intentions? 
3. Are there any individual or work-related variables that are significantly associated 
premenstrual symptom severity? 
4. To what extent are premenstrual symptoms and their consequences on work being 
disclosed to line managers and why? 
5. What recommendations and suggestions do staff have for employing organizations 
and line managers to support and help staff with work difficulties associated with 
premenstrual symptoms? 
2. Materials and Methods 
Female members of a UK trade union and professional association for family court 
and probation staff in England, Wales and Northern Ireland were invited to complete an 
anonymous electronic survey. The trade union were interested in working with academics 
to understand the menopause and premenstrual experiences of their members. The sur-
vey was created by the authors to investigate the experience, attitudes, and recommenda-
tions of female members of these reproductive health topics. The survey collected quali-
tative and quantitative data. 
Female members were invited to complete the anonymous electronic survey via an 
email that was distributed from an internal contact within the trade union. The email con-
tained a brief description of the study, the researchers’ contact details, and the link to the 
survey. There were approximately 500 female members across six geographical areas that 
could be contacted via their email address at the time of the survey. 
The survey was hosted on the platform SurveyMonkey and took approximately 20 
min to complete. Before participants completed the survey, they were presented with de-
tails of the purpose and scope of the study. Participants were informed that the survey 
was anonymous and voluntary. They were invited to click a consent box before being 
allowed to complete the survey questions. The survey had to be completed in one sitting 
and could be done using a desktop, tablet, or mobile phone device. It was first piloted 
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with five people, including three women from within the trade union and two academic 
researchers with knowledge and expertise in survey design. This was done to ensure lan-
guage, content, and length were acceptable before conducting the main data collection. 
Ethical approval for this study was granted from the Ethical Review Committee at 
King’s College London (reference number: HR-15/16-2492). Feedback on the results was 
provided in both an internal summary feedback report for the union and presented at 
their annual Women’s Conference. 
2.1. Measures 
Self-report data was collected from participants classified as premenopausal (i.e. only 
respondents who were having regular menstrual periods for them) and were not preg-
nant. The survey included questions from pre-existing measures and bespoke items to 
gather quantitative and qualitative data of interest for the trade union member survey. 
2.1.1. Individual and Work-Related Variables 
Demographic and health-related questions included (see Supplementary Table S1 for 
all response options): age, ethnicity, educational level, sexuality, relationship status, and 
whether they had dependents/caring responsibilities. Health and wellbeing questions in-
cluded: general health (5-point scale, 1 (poor) to 5 (excellent)) [24], body mass index (BMI), 
weekly exercise frequency (1 (rarely/never) to 6 (every day), weekly alcohol intake (1 (none), 
2 (1–6 units per week), 3 (7–13 units per week), 4 (+14 units per week)), smoking status 
(never, ex-smoker, or smoker), sleep quality (4-point scale item, 1 (very good) to 4 (very 
bad), from the Pittsburgh Sleep Quality Index (PSQI) [25]), levels of depression (7 items 
using a 4-point scale: 1 (not at all), to 4 (nearly every day), example item “Feeling nervous, 
anxious or on edge”, α = 0.92, GAD-7, [26]) and anxiety (9 items using 4-point scale: 1 (not 
at all), 2 (several days), 3 (more than half the days), 4 (nearly every day), example item 
“little interest or pleasure in doing things”, α = 0.89, PHQ-9, [27]). 
Work-related variables included (see Supplementary Table S2 for all response options): 
weekly working hours, work status, work patterns/shift work, flexible working, type of work, mana-
gerial/supervisory responsibilities, and the sector in which they worked. Perceptions of work 
questions included: job satisfaction (single item, 7-point scale: 1 (extremely dissatisfied) to 
7(extremely satisfied) [28]), job stress (4-point scale: 1 (not stressful) to 4 (extremely stressful) 
[29]), work–life balance (3 items, example item “I manage to balance the demands of my work 
and personal/family life well”, 5-point scale: 1 (strongly disagree) to 5 (strongly agree), α = 
0.90 [30]), employee psychological resilience (single item, 1(low resilience) to 9 (high resilience), 
[31]. Participants’ perceptions of their working environment was measured using the UK’s 
Health and Safety Executive’s Management Standards Indicator Tool (MSIT), 35 items using 
a 5-point scale: 1 (never or strongly disagree) to 5 (always or strongly agree)) [32]) that fo-
cuses on six aspects associated with causing stress at work if poorly managed: job demands 
(8 items, example item “I have to work very fast”, α = 0.85), control (6 items, example item “I 
can decide when to take a break”, α = 0.86), support (from manager and peers, 9 items, ex-
ample item “I am supported during emotionally demanding work”), α = 0.88), relationships 
at work (4 items, example item “I Relationships at work are strained”, α = 0.76), role clarity 
(5 items, “I am clear what is expected of me at work, α = 0.87), and how change is managed 
at work (3 items, example item “Staff are always consulted about change at work”, α = 0.82),. 
Risks are identified by lower scores on these scales, apart from demands and relationships 
where higher scores indicate greater risk. 
2.1.2. Premenstrual Symptom-Related Variables 
Several questions were included to understand premenstrual symptoms and related 
areas of interest (see Supplementary Table S3). These included the prevalence and severity 
of premenstrual symptoms using the 19 item Premenstrual Screening Tool (PSST) [33], which 
categorizes respondents’ symptom(s) severity into no/mild, moderate (PMS) or severe 
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(PMDD) from responses to 14 premenstrual symptoms and their impact on different life 
domains using a 4 point scale (1 (not at all) to 4 (severe)). The duration of premenstrual 
symptoms (in days), how long symptoms had been experienced (years), and whether partici-
pants had sought professional help for their premenstrual symptoms in the last 6 months 
was also asked in the survey. Hormonal contraception use was collected and participants 
perceived ability to cope with premenstrual symptoms on five premenstrual coping pro-
cesses measured by the Premenstrual Coping Measure (PMCM) [34]: avoiding harm (8 
items, example item “I avoid situations that have the potential to provoke me”, α = 0.92), 
awareness-acceptance of premenstrual change (10 items, example item “I accept my change-
able moods”, α = 0.95), adjusting energy (5 items, example item “I exercise less”, α = 0.84), 
self-care (4 items, example item “I allow myself extra time to rest”, α = 0.92), and communi-
cating (5 items, example item “I ask for help from others”, α = 0.74) using a 5 point response 
scale (1 (doesn’t apply to me) to 5 (almost always applies to me)).  
2.1.3. Work Outcome Variables 
Several work outcomes were examined including (see Supplementary Table S3 for 
all response options) overall perceptions of job performance (5-point scale: 1 (poor), 5 (ex-
cellent), [35]), presenteeism (the short-form Stanford Presenteeism Scale (SPS-6) [36]) exam-
ining participants ability to be fully present at work, concentrate and accomplish tasks 
despite of premenstrual symptom concerns or difficulties (6 items, example item “Despite 
having my premenstrual symptoms, I was able to finish hard tasks in my work”, α = 0.78, 
using a 5-point scale: 1 (strongly disagree) to 5 (strongly agree)), the degree of work absence 
because of premenstrual symptoms, and general turnover intentions. Specifically, work ab-
sence was examined by asking if participants had (response options:” yes”, “no”, “some-
times”): (i) ever any absence taken because of premenstrual symptoms, (ii) had to leave work 
early, or (iii) arrived at work late because of premenstrual symptoms. For those that had 
taken one of these forms of work absence, (iv) whether this had occurred in the last four 
weeks and if so, the number of days affected by absence. Turnover intentions were explored 
in terms of whether participants had considered: (i) reducing their working hours, (ii) leaving 
the workforce altogether, and (iii) leaving their current employing organization (4 items, exam-
ple item “How do you feel about leaving this organization? α = 0.83, using a 5-point scale: 
1 (definitely not leave), 3 (uncertain), 5 (definitely leave) [37]). 
2.1.4. Disclosure, Recommendations and Suggestions for Organizations and Line Man-
agers 
With regard to disclosure, participants were asked to indicate (using “yes”, “no”, 
“sometimes” response options) whether they had (i) ever disclosed to line managers about 
their premenstrual symptoms and work-related difficulties, and, for participants who had 
taken time off work because of their premenstrual symptoms, (ii) did they disclose this as 
the reason for their work absence to their line managers. Open-ended questions followed 
and asked participants to share the reasons for deciding to disclose (or not) to their line 
managers. 
Finally, open-ended response questions were used in the survey to gather data on 
women’s views on how employing organizations and line managers might better support 
staff experiencing premenstrual symptom-related difficulties at work. Participants were 
asked: (i) what they thought would be useful for employers/organizations to do to support 
staff, and (ii) what line manager behaviors would be helpful and unhelpful. 
2.2. Analysis 
Both quantitative and qualitative analyses were used in this study. Descriptive and 
inferential analyses are performed on quantitative data to understand the sample and re-
sponses overall, as well as to address the specific research questions posed in this paper. 
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For research question 1, descriptive statistical analyses were used to report on the preva-
lence and severity of premenstrual symptoms in the sample. To address research ques-
tions two and three, the moderate and severe premenstrual symptom severity groups 
were combined to create a dichotomous premenstrual symptom severity outcome varia-
ble (no/mild symptoms vs. moderate/severe symptoms) for the subsequent analyses. Pear-
son Chi-Squared analyses were used and, when required, Fisher’s Exact output was use 
for interpretation (see [38]). Statistical significance was assumed at the 0.05 level of prob-
ability. The statistical software package SPSS (version 25, IBM Corp., Armonk, New York, 
USA) was used. 
The qualitative data from the open-ended responses were analyzed using an inductive 
thematic analysis approach, following the guidance by Braun and Clarke [39]. The research-
ers adopted an explicit, surface-level meaning of the data within a realistic epistemological 
position (i.e., interpretation did not attempt to go beyond the data or words that were pro-
vided). The first author [CH] performed the initial analyses and the second author [MSH] 
reviewed the data and thematic structure to determine if interpretation was agreed. Any 
differences were discussed and a final set of themes were agreed. Themes were determined 
using the frequency of codes whereby similar codes were grouped to create a theme. The 
computer software package NVivo (version 12, QSR International Pty Ltd., Burlington, MA, 
USA) was used. Analyses were performed separately to develop themes related to thematic 
structures for responses related for employers and organizations, and for line managers be-
haviors. The emergent themes between the analyses overlapped considerable and results 
are discussed together in the results section below. 
3. Results 
3.1. Overall Sample Characteristics 
One-hundred and twenty-five pre-menopausal women completed the survey and 
were included in the analysis (one participant had been removed because they were preg-
nant at the time of completing the survey and therefore had not been experiencing men-
strual cycles). They were (see Supplementary Table S1) were, on average, in their late thirties 
(M = 38.79 years), in a relationship (71.8%), and 90% were heterosexual. Just over half had 
children to care for (57.3%), and few had other dependents or caring responsibilities (11.3%). 
Respondents were predominantly white (87.8%), educated to degree level (90.4%), and 
healthy. Most women were non-smokers (87.2%), took weekly exercise (72.0%), and con-
sumed 1–6 units of alcohol per week or less (76.8%). The average BMI score for the sample 
was 27.81 (range 17.10–47.20) and within the overweight range [40]. However, 71.2% of the 
sample rated themselves as having good to excellent general health (M = 2.97, SD = 1.03), 
49.6% having good quality of sleep, with mild to moderate levels of anxiety (M = 8.20, SD = 
5.85) and depression (M = 7.10, SD = 5.53) [41]. Approximately two-thirds of the sample were 
using hormonal contraception (67.5%, see Supplementary Table S3). 
In terms of their work (see Supplementary Table S2), participants worked an average 
of 39 h per week (range 15–55 h), were full-time (77.6%), had regular patterns of working 
hours during the day (87.8%), and almost two thirds could work flexibly (62.6%). The 
majority had non-manual jobs (98.4%), with no managerial responsibilities (85.4%). On 
average, the sample were neither satisfied or dissatisfied with their jobs (M = 3.92, SD = 
1.47); just under half were satisfied in their jobs (44.7%). However, they did appear to have 
high levels of job stress (80.6% moderate-severe responses) with a somewhat poor work–
life balance (M = 2.55, SD = 0.77) with around a third (30.4%) overall showing agreement 
work–life balance agreement They also perceived themselves to have some personal re-
siliency to ‘bounce back’ from a change or setback from work with just over half (55.0%) 
indicating higher levels. With regard to aspects of their working environment, the re-
sponses appeared mixed; average scores suggest the sample had fairly good role clarity 
(M = 3.73, SD = 0.69), support (M = 3.45, SD = 0.78), relationships (M = 2.71, SD = 0.48), and 
control over their jobs (M = 3.20, SD = 0.66), but may be experiencing high job demands 
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(M = 3.54, SD = 0.78), and poor experiences of how changed is managed at their workplace 
(M = 2.46, SD = 0.96). 
In terms of the work outcomes (see Supplementary Table S2), on average the sample 
felt they were performing their jobs well in comparison to others in a similar position with 
74% rating themselves as high to excellent. Average scores on presenteeism showed that 
the sample felt able to overcome premenstrual symptoms in order to carry out their work 
duties well and be productive (M = 20.88, SD = 5.17) with only 5% scoring below 12 sug-
gesting they did not feel able to overcome their premenstrual symptoms at work. Overall, 
there were fairly low levels of turnover intentions with a quarter (25.6%) considering leav-
ing the workforce and around a third (31.2%) probably or definitely intending to leave 
their current employing organization. However, around half (49.6%) had, or were consid-
ering, reducing their working hours. 
Premenstrual symptom-related work absence was reported by around a quarter of 
the sample (21.2%); 14.6% had taken time off work due to their symptoms either a full day 
off, 21.2% have had to leave work early and 16.0% arrived at work late due to their pre-
menstrual symptoms. Of those who had ever taken time off work (n = 18), few had done 
so in the last 4 weeks (11.1%), which lasted either 1 or 2 days in duration. 24.0% of those 
that had arrived at work late (n = 25) had done so in the last 4 weeks, mostly on one occa-
sion/day (66.7%). A third (36.8%) of those that had arrived late (n = 19) had done so in the 
last 4 weeks, mostly one a single occasion/day. 
3.1.1. Research Question 1. Premenstrual Symptom Prevalence and Severity 
Over 90% of this sample reported that they had experienced at least one premenstrual 
symptom in the last 4 weeks; of these, 91.2% had experienced physical symptoms such as 
breast tenderness, headaches, or joint/muscle pain, bloating, weight gain; 84.5% experi-
encing fatigue/lack of energy; 93.9% experiencing anger or irritability. Symptoms (see 
Supplementary Table S3) lasted on average around 5 days and ranged between 1–14 days. 
Respondents in this study had been experiencing them for an average of 15 years (range 
1–40 years). Just under a quarter (21.0%) had sought professional help for their premen-
strual experiences (see Supplementary Table S3). 
In terms of premenstrual symptom severity, just under two-thirds (60.8%) experi-
enced no or mild premenstrual symptom severity whilst around 40% had experienced 
moderate (34.4%) to severe (4.8%) premenstrual symptom severity in the last 4 weeks, 
which affected their normal functioning and could potentially receive a diagnosis of PMS 
and PMDD, respectively. 
3.1.2. Research Question 2. Associations between Premenstrual Symptom Severity and 
Work Outcomes 
Female staff experiencing moderate to severe premenstrual symptoms reported sig-
nificantly lower presenteeism scores compared to those with mild and no premenstrual 
symptoms, suggesting there were less able to overcome their symptoms and their work 
performance was being affected. There were no statistically significant group differences 
for perceived job performance, nor turnover intentions compared to those with no or mild 
premenstrual symptoms (see Table 1). 
Table 1. Results of independent t-tests between premenstrual symptom severity and job performance, presenteeism, and 
intention to leave the current employing organization (turnover intention). 







Job performance 75 M = 3.97 (SD = 0.75) 48 M = 3.75 (SD = 0.73) 1.62 0.12 
Presenteeism 1 74 M = 22.80 (SD = 4.81) 47 M = 17.87 (SD = 4.21) 5.93 0.00 *** 
Turnover intention 2 76 M = 3.07 (SD = 1.14) 49 M = 3.17 (SD = 0.86) −0.53 0.60 
1 Related to premenstrual symptoms, 2 Intention to leave the current employing organization; M = Mean, (SD = standard 
deviation); *** p < 0.001. 
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Table 2 shows the rates of absence comparing the no/mild premenstrual symptom 
severity group and those in the moderate to severe severity group. Significant associations 
were found between severity of premenstrual symptoms and absence levels. The odds 
ratios suggest that when compared to staff with no/mild premenstrual symptoms, staff 
with moderate/severe symptoms were 5.20 times more likely to have taken time off (χ2(1) 
= 9.77, p < 0.01), 6.27 time more likely to have left work early (χ2(1) = 15.42, p < 0.001), and 
12.40 times more likely to arrive at work late because of their premenstrual experiences 
(χ2(1) = 19.79, p < 0.001 (Fisher’s Exact). Work absence in the last 4 weeks contained too 
few data to perform analyses. 
Intentions to reduce working hours were significantly higher in the group with mod-
erate/severe premenstrual symptoms compared to those with no/mild premenstrual 
symptoms (χ2(1) = 4.36, p < 0.05). The odds of participants intending to reduce their hours 
were 2.17 higher in participants with moderate/severe premenstrual symptoms than 
no/mild symptoms. No statistically significant associations with intentions to leave the 
current employing organization or the workforce. 









Work Absence 1:    
(i) Ever taken time off 
No 70 35 
Yes 5 13 
(ii) Ever left early 
No 66 27 
Yes 7 18 
(iii)Ever late 
No 70 30 
Yes 3 16 
Turnover Intentions:    
(i) Intention to reduce working 
hours 
No 44 19 
Yes 32 30 
(ii) Intention to leave work-
force 
No 60 33 
Yes 16 16 
1 Related to premenstrual experiences. 
3.1.3. Research Question 3. Associations between Premenstrual Symptom Severity and 
Individual- and Work-Related Variables 
With regard to individual-related variables, staff with moderate/severe premenstrual 
symptoms compared to staff with no/mild symptoms (n = 49 v N = 76) had significantly 
poorer levels of general health (M = 2.74, SE = 0.13 vs. M = 3.12, SE = 0.12; t(123) = 2.06, p < 
0.05), consumed higher amount of alcohol (M = 2.33, SE = 0.12 vs. M = 1.84, SE = 0.08; t(123) 
= −3.39, p < 0.01), had poorer sleep quality (M = 2.82, SE = 0.12 vs. M = 1.84, SE = 0.08; t(123) 
= −2.96, p < 0.01), and were feeling more depressed (M = 10.57, SE = 0.85 vs. M = 6.68, SE = 
0.61; t(123) = −5.04, p < 0.001) and anxious (M = 9.94, SE = 0.79 vs. M = 5.28, SE = 0.55; t(123) 
= −3.82, p < 0.001). There were significantly fewer participants with moderate to severe 
premenstrual symptoms using hormonal contraception than not (n = 8 vs. n = 39, χ2(1) = 
6.45, p < 0.05)) compared to staff with no or mild premenstrual symptoms (n = 28 vs. n = 
44). In addition, those with moderate/severe premenstrual symptoms less frequently used 
the premenstrual symptom coping strategies of avoiding harm (M = 2.95, SE = 0.12 vs. M 
= 2.09, SE = 0.11) and adjusting their energy (M = 3.24, SE = 0.12 vs. M = 2.27, SE = 0.12), 
compared to staff with no/mild symptoms 
With regard to work-related variables, participants with moderate/severe premen-
strual symptoms compared to staff with no/mild symptoms reported significantly poorer 
work–life balance (M = 2.19, SE = 0.14 vs. M = 2.78 SE = 0.12; t(123) = −1.90, p < 0.01) and 
lower psychological resiliency (M = 5.04, SE = 0.29 vs. M = 6.03, SE = 0.24; t(120) = 2.60, p < 
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0.01). In relation to the perceived working environment, participants with moderate/se-
vere premenstrual symptoms (n = 49) compared to staff (n = 76) with no/mild symptoms 
reported significantly higher perceived job demands (M = 3.79, SE = 0.10 vs. M = 3.39, SE 
= 0.09; t(123) = −2.89, p < 0.01) and less control over their work (M = 3.01, SE = 0.09 vs. M = 
3.32, SE = 0.07; t(123) = −2.63, p < 0.05. There were no other significant between group 
differences in other individual or work-related variables. 
3.1.4. Research Question 4. Line Manager Disclosure for Premenstrual Symptoms and 
Work Absence 
Overall levels of disclosure to line managers about premenstrual symptoms were 
very low (8.9%, n = 11), and occurred more often amongst women with moderate/severe 
premenstrual symptom severity (n = 7) than those with no/mild symptoms (n = 4). In par-
ticular, less than less than half (44.4%) of participants who had taken some form of work 
absence (including being late or leaving work early) because of their premenstrual symp-
toms (n = 18) had disclosed that the real reason for their absence was because of their 
premenstrual symptoms. 
Twenty-six women provided responses to the open-ended questions about disclo-
sure. Of these, two women had disclosed their premenstrual symptoms and need for tak-
ing work absence to their line manager. The main reason for their disclosure was because 
of the severity or difficulty of the symptoms, which were very high (e.g. “Extreme pain. 
Needing to take pain killers that are so strong I cannot safely drive on them, so I need to get home 
before the pain is so bad I can’t drive”). 
The majority of responses were from staff who had not disclosed the real reason for 
absence (n = 20) or had only sometimes disclosed the main reason (n = 4). Just under half 
of these participants (45.8%, n = 11) said the main reason for not disclosing was because 
they felt that premenstrual problems were not a valid reason for needing to take sickness 
absence from work (e.g. “feeling exhausted because of a menstrual cycle is not viewed as a gen-
uine reason to take time off work, it is part of everyday life” and “Felt that was not a valid expla-
nation”). Some staff felt that they would not be believed or would be dismissed if they said 
they were having difficult premenstrual problems (e.g. “I feel I wouldn’t be believed”). This 
may relate in some cases to the gender of the line manager (e.g. “Frequently have male man-
agers who I know would be embarrassed, or who have expressed dismissive views of women on their 
periods”), which over a third of these women said was another main reason given for none 
disclosure of PMS (37.5%, n = 9). Respondents felt that men would be too embarrassed 
(e.g. “I have a male manager who would probably die of embarrassment”) and would prefer to 
disclose to a female manager. Although, this was not universal; there was some mention 
that female managers may also be unapproachable or unsupportive (e.g., “Would expect 
very little sympathy from her”) because they not have difficult premenstrual symptoms (e.g., 
“also had female managers who say, “I manage fine!””). These responses suggest that line man-
agers who do not have their own lived experiences of premenstrual symptoms may be 
influencing these disclosure behaviors. 
Another reason given for not disclosing was the nature of the topic being too per-
sonal. A quarter of respondents (25.0%, n = 6) noted that the topic was perhaps too em-
barrassing or uncomfortable to discuss with their line manager and will instead give some 
other health reason (e.g. “Not comfortable in doing this. Will report headache or other symptoms 
but not be specific about why”). Some respondents, again, made reference that this personal 
“women’s” topic is not something that male colleague experience. As a consequence, they 
are reluctant to disclose for fear of being perceived as unable to do their job (e.g. “I think 
this makes me look weak at work. I need to be able to do my job regardless of what is going on for 
me as a woman. Particularly as my males colleagues do not experience this”). 
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3.1.5. Research Question 5. Recommendations and Suggestions for Employing Organiza-
tions and Line Manager Behavior 
Fifty-six participants provided suggestions or recommendations for employing or-
ganization about supporting staff who may be experiencing difficult premenstrual symp-
toms at work. Six main recommendations and suggestions were mentioned: showing un-
derstanding and acceptance (33.3%, n = 26), flexibility (25.6%, n = 20), the physical work envi-
ronment (10.3%, n = 8), talking (9.0%, n = 7), health and wellbeing resources (7.7%, n = 6), and 
procedures and policies (7.7%, n = 6). Sixty-two participants provided suggestions and rec-
ommendation for line manager behaviors. There were four main themes including (in or-
der of prevalence) acknowledgment and understanding (58.0%, n = 91), talking and use of lan-
guage (21.0%, n = 33), allowing flexibility and workload adjustments (17.2%, n = 27), and the 
work environment and absence management (3.1%, n = 6). These themes show similar and 
inter-related recommendation and suggestions for organizations and line managers and 
will therefore be discussed together below. 
Showing Understanding and Acceptance 
Recommendations for employers emphasized the need for understanding of these 
female health-related experiences and accepting that they happen. This should be done 
without judgment and being empathic toward staff who are affected (e.g. “More knowledge 
and understanding for line managers. Just because my line manager is fine does not mean I am”). 
Respondents believed that female staff should know it is acceptable to be affected by their 
premenstrual symptoms and to speak-up and ask for support or time off. Demonstrating 
such beliefs by showing support that these women are not fabricating their symptoms and 
experiences (e.g. “belief that it is a real problem and not just an excuse women use”). Employing 
organizations should be being mindful that these premenstrual symptoms and experiences 
can occur and employers should show staff their support when staff experiencing difficul-
ties related to their premenstrual symptoms. 
Line managers were given similar suggestions including acknowledging these types of 
staff difficulties in relation to premenstrual symptoms, and being understanding and sup-
portive towards these staff (e.g. “Just be understanding”, “acknowledge that it affects us”). Line 
managers were advised to be sensitive towards staff and show empathy. Respondents high-
lighted that it is important for managers to be non-judgmental and trust what staff are ex-
periencing and disclosing. These premenstrual experiences should be taken seriously and 
treated like any other health condition. Conversely, unhelpful behaviors in relation to this 
theme were expressed as line managers being dismissive, not believing staff who are expe-
riencing problems, as well as ignoring the staff members’ problem as all together (e.g. “Ig-
nore or be dismissive”). Not being believed can make the situation worse for some staff (e.g. 
“Make you feel worse by not accepting it’s a real issue”). Showing a lack of empathy, understand-
ing and support was consistently highlighted as unhelpful behaviors that managers could 
respond with as it can make the member of staff feel that their experiences are not im-
portant and undermine them (e.g. “Undermine how you’re feeling”. This includes making 
assumptions and underestimating experiences, along with making staff feel guilty or that they 
are letting others down because they cannot complete a particular task or objective (e.g., 
“Not make you feel like a worthless piece of shit for being a woman with difficult periods. Not make 
you feel like you’re letting other people down because you’re sick with something that isn’t your 
fault. Not make you feel guilty if a target is missed because you’re sick and in pain”). 
Appropriate Talking and Communication 
The importance of talking and communication was raised across responses. Some 
respondents mentioned that there should be more talking about this issue, including in 
public that could help raise awareness and facilitate acceptance (e.g. “make it more spoken 
about in public”) as suggested in the above theme. In addition, employers could consider 
having a policy, which could involve staff training and promote more communication and 
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talking about this health topic (e.g. “Have a clear policy around this issue which would promote 
its discussion particularly with male managers who in my experience would struggle to discuss 
anything linked to women’s reproductive cycles”). 
Suggestions for line managers communication and their use of language highlighted the 
importance for line managers to talk openly, in an “adult way” and avoid phrases or 
words that are considered disrespectful, unhelpful or inappropriate (e.g. “Talk about it 
openly and in an adult way, too many people find it gross and/or a skive”). In addition, line 
managers should not make jokes about premenstrual symptoms and not use sexist, patroniz-
ing, or negative remarks that might insinuate staff that menstruate is a negative situation 
(e.g. “Use words like ‘yuck’ eugh’ ‘that’s gross’ when talking about periods. It’s just blood. Yet so 
many people get grossed out by it”). For example, some phrases to be avoided including “are 
you premenstrual??”, “we all have to deal with it”, or “you seem premenstrual”). 
Conversely, if staff do talk about their premenstrual symptoms and difficulties at 
work, it is important that line managers listen so that they can understand what the mem-
ber of staff is experiencing and be able to manage the situation in a more tailored/individ-
ual and appropriate way (e.g. “discuss how it affects you so they can be aware of how you’re 
feeling each month” and “asking if they need flexible working for a couple of days”). Being too 
intrusive, however, should be avoided. Treating the conversations as confidential is also 
important and not sharing the member of staff’s experience with others. Respondents high-
lighted this to be a common experience by female staff. Conversation should not be 
avoided but instead handled in a suitably respectful way. 
Accommodating Policies and Flexibility 
The importance of being flexible towards women’s working and having appropriate 
policies and procedures in place to permit these to happen were recommended (e.g. “en-
able flexible working”). Allowing staff to work flexibly and have more control over their 
workloads and how they do their tasks was a suggested helpful approach to take. Allow-
ing workloads to be adaptive to a member of staff’s their menstrual cycle could be useful. 
Respondents suggested that allowing female staff to adjust their work, the hours, and be 
able to have more flexible working to accommodate the days when they need to not be at 
work, doing certain tasks, or perhaps, need to take some of the workload off could be very 
useful for employers and for line managers. 
In addition, ensuring workloads and deadlines were not “unrealistic” were also high-
lighted as something important for employers to ensure (e.g. “stop giving unreasonable 
workloads”). During the premenstrual phase staff may need some temporary allowances 
or adjustments to their workload. Some women felt that they were being penalized be-
cause they were sharing their health difficulties and not being supported in a way they 
felt they needed. Therefore, having policies in place to allow these members of staff to 
have temporary adjustments to their work without penalties is encouraged. For example, 
not recording days taken off work because of difficult premenstrual symptoms would be ben-
eficial, as this would avoid the procedure of investigation into why staff are taking time 
off work to be triggered (e.g. “Don’t count days taken off with period pain as sick days. Other-
wise people end up on sickness procedures over a medical condition they have no control over”). 
As premenstrual symptoms are recurring and common, it was considered better to avoid 
these investigations because staff cannot help experiencing these difficulties but they 
might result in disciplinary action towards the member of staff for taking too much time 
off at work. It was acknowledged that female staff should be able to take time off work if 
they are not well enough to attend and they should not be made to feel guilty or penalized. 
Appropriate Resources and Work Environments 
Offering staff health and wellbeing resources was another suggestion by some re-
spondents (e.g. “Offer health and wellbeing sessions looking at diet…No one ever seems to make 
this connection…exercise and lifestyles”), which included having menstrual products avail-
able at work, and forms of treatment that could be offered by workplaces or subsidized. 
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Addressing aspects of the work environment were also highlighted. This included both 
physical aspects of the workplace making sure they are fit for purpose. Suggestions made 
included making sure toilets had sinks in them, private rooms that were quiet to take a 
rest, and generally that facilities are considered in relation to these menstrual health issues 
(e.g. “consider their buildings with regards to toilets, comfort areas etc., as many tend not to be fit 
for purpose”). Non-physical aspects of the work environment were also noted such encour-
aging a good work–life balance (e.g. “encourage better work life balance including exercise”) 
and promoting a safe space for women at work (e.g. “Create an environment where women 
feel they have a voice. I work in a heavily female environment but most of the managers are men”). 
Other suggestions included making sure the physical work environment was fit for purpose. 
These included making sure toilets had sinks in them, private rooms that were quiet to 
take a rest, and generally that facilities are considered in relation to these particular health 
topics too (e.g. “consider their buildings with regards to toilets, comfort areas etc., as many tend 
not to be fit for purpose”). 
4. Discussion 
This study explored the topic of premenstrual symptom experiences in the work con-
text. We found that premenstrual symptoms were highly prevalent in this UK sample. 
Around 40% experienced moderate to severe symptoms that impaired normal function-
ing. This includes 5% with levels of symptom severity that may qualify for diagnosis of 
PMDD and 35% PMS. These rates align with those found in some other populations pre-
viously studied whereby 40% females have symptoms of PMS [42], although slightly 
lower than the recent global-pooled estimate [2]. The observed prevalence rates severe 
premenstrual symptoms (and a possible PMDD diagnosis) also concur with previously 
published rates of PMDD of between 5–8% [7]. However, there are reported variations 
depending on the methods used to identify and diagnoses PMS and PMDD [8]. 
Premenstrual symptom severity was associated with several work outcomes. Staff 
with moderate/severe symptoms were found to be significantly more likely to perceive 
their premenstrual symptoms as preventing them from being fully present and able to 
carry out their job (i.e., presenteeism), take time off work because of their premenstrual 
symptoms, leave early because of their symptoms, and more likely to arrive at work late 
because of their symptom severity. Previous research has also shown higher rates of work 
absence in staff with more severe premenstrual symptoms, including partial days off be-
cause of their premenstrual symptoms (e.g. [14–18,20]). The importance of considering 
presenteeism, including staff experiencing difficulty in concentrating during their pre-
menstrual “episode” phase, has been highlighted in previous studies [17,23], which the 
present study confirmed its importance. A previous study making the impact of PMDD 
on work highlighted that the long-term impact of working through difficult premenstrual 
symptoms may be that staff leave the workforce and the careers [17]. The present study 
also showed that intentions to reduce working hours did not coincide with intentions to 
leave the employing organization or the workforce. It may therefore only be staff with 
very high severity and/or having experienced these symptoms over a login period of time 
where these turnover intentions may occur. Longitudinal research is needed to examine 
this further. With regard to reducing working hours, implications of this finding suggest 
that female staff working part-time may be more likely to have moderate/severe symp-
toms. If so, providing support and work adjustments to address or work around these 
symptoms may be able to help staff work more hours. Recommendation and suggestions 
for such support to staff are provided in this study. However, again, longitudinal research 
would be needed to examine this further. 
The present research found no significant differences in job performance. Previous 
studies have shown lower job performance and productivity levels in staff with more se-
vere premenstrual symptoms compared to those with no/mild severity (e.g. Borenstein 
and colleagues [13,14). The different results may relate to differences in the measurements 
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used to calculate job performance and work productivity, or because of the samples in-
vestigated who may be from different sectors and/or countries. Future research using ob-
jective measures of job performance and output may therefore be useful and offer a way 
to make more consistent comparisons across different samples. 
A number of individual and work-related variables were significantly associated 
with premenstrual symptom severity. This included levels of general health, alcohol con-
sumption, quality of sleep, levels of depression and anxiety, use of hormonal contracep-
tion and using premenstrual coping strategies of avoiding harm and adjusting energy. 
Aspects of work associated with premenstrual symptom severity included perceived 
work–life balance, psychological resiliency to change, and perceived job demands and 
control. Previous research exploring risk factors related to premenstrual symptoms im-
pacting on normal functioning have identified alcohol intake, smoking, weight gain, as 
well as depression [8] as key factors associated with PMS. Work–life balance was also 
suggested in a previous qualitative study on staff with PMDD [17]. The other variables 
found in this study therefore support and build upon previous research to help identify 
possible risk factors that may be appropriate to consider and address when examining 
premenstrual symptoms in the work context. 
Disclosure of premenstrual symptoms to line managers was very low and occurred 
more in staff with moderate to severe premenstrual symptoms. Disclosure was signifi-
cantly higher when women had severe symptoms and needed to be off work. However, 
those who decided not to disclose revealed it was due to perceiving that premenstrual 
symptoms would not be seen as a valid reason for needing absence, it would be discrim-
inated, and or cause embarrassment. This was particularly in relation to male line manag-
ers but not always as some female managers were also regarded as unapproachable or 
unsupportive. Some staff felt the issue was too personal and sometimes gave another 
health reason for taking time off work and were fearful that if they gave the real reason 
they would be perceived as unable to do their job. These findings support previous re-
search highlighting concerns regarding disclosure of experiencing or taking sickness ab-
sence related to problematic premenstrual symptoms [17]. Similar problems around dis-
closure of health problems can also be found for other health topics, such as mental health 
[43], being HIV positive [44], or the menopause, which are also often considered a taboo 
and stigmatized health topic in the work context [22,28,45]. The implications of not dis-
closure difficulties, or giving another reason for absence, may mean that line managers 
and employers are unaware of the difficulties some of their staff may be experiencing and 
in turn, not offer appropriate support and work adjustments. 
This study also highlighted several key areas that employers, line managers may be 
able to address that would help female staff experiencing premenstrual symptoms and 
difficulties from the perspective of female staff. These centered around the importance of 
awareness and acceptance of premenstrual symptoms and the potential difficulties that 
they may temporarily cause for some staff. Being open and facilitating talking and com-
munications about this health topic at work, having policies and practices that can accom-
modate this health topic, and providing resources and a “fit for purpose” working envi-
ronment. Specific recommendations and suggestions for employers and line mangers pro-
vide clear implications for policy, practice and further research. For example, developing 
training and resources for organizations and line managers. These suggestions may also 
be of interest to other key stakeholder such as researchers, policy makers, trade unions, 
and government bodies that aim to improve the health and wellbeing of the workforce to 
enhance economic participation. Future research examining the impact of COVID-19 on 
the working lives of women and how this may influence premenstrual symptom experi-
ences and suggestions for working would also be of value for this topic. 
Given that the UK has over 10.5 million women in employment aged between 16–49 
years [46] there may be a significant proportion of staff may be working through phases 
of premenstrual related difficulties on a monthly basis. In particular, staff with moderate 
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to severe premenstrual symptoms may experience a significantly impaired ability to com-
plete their work as normal and avoid distractions at work. They may also be more likely 
to time off work, especially at the start of their work shift, and consider reducing their 
working hours. In addition, these issues may be likely to go unknown because of low 
levels of disclosure of these health difficulties. The research therefore presents timely 
work as there is growing interest in reproductive health as a public health issue, particu-
larly in the UK [47]. 
This study has provided new insights into this under-researched health area and di-
rections for future research, policy and practice in organizations. However, limitations of 
the research include the cross-sectional design of the study, which limits the ability to infer 
causation, for example, it cannot be ascertained whether premenstrual symptom severity 
causes the impairments in work outcomes or vice versa. With larger samples and a longi-
tudinal design, it may be possible to control for additional variables (e.g., hormonal con-
traception use, depression, anxiety) to determine the extent to which work factors may be 
causing or influencing these premenstrual symptom severity levels and which are the 
most important to address. In addition, the depth of the qualitative analysis and interpre-
tation was limited by the amount of data provided in the open-text boxes by participants. 
Other methods of gathering qualitative data, such and interviews and focus groups, 
would have allowed more in-depth insight into the reasons and explanations given and 
explore possible relationships between the themes and factors identified here in this 
study. The results found in this study may therefore serve as a useful guide to inform 
future research. 
5. Conclusions 
This study examined women’s experience of premenstrual symptoms in the work 
context. It has shed light on the prevalence and severity of premenstrual symptoms in UK 
working women, individual and work-related factors associated with symptom severity, 
association with different work outcomes of interest, levels of disclosure and the reasons 
behind deciding to disclose (or not), and finally, recommendations and suggestion for or-
ganizations and line managers from the female staff perspective. The work highlights the 
large proportion of women affected by premenstrual experiences, the impact this may 
have on work and what changes might be helpful for women, managers and organisa-
tions. 
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